| Nome |
# |
|
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice, file dfe4d22b-67d2-bb0a-e053-d805fe0a78d9
|
82
|
|
New insights in thyroid cancer and p53 family proteins, file dfe4d227-e5e3-bb0a-e053-d805fe0a78d9
|
58
|
|
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications, file dfe4d22e-cbfe-bb0a-e053-d805fe0a78d9
|
51
|
|
Opportunities and challenges of liquid biopsy in thyroid cancer, file dfe4d22e-7e31-bb0a-e053-d805fe0a78d9
|
48
|
|
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells, file dfe4d22e-6b29-bb0a-e053-d805fe0a78d9
|
41
|
|
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily, file dfe4d22e-c72d-bb0a-e053-d805fe0a78d9
|
41
|
|
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts, file dfe4d22e-6c5b-bb0a-e053-d805fe0a78d9
|
38
|
|
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?, file dfe4d22e-ae2d-bb0a-e053-d805fe0a78d9
|
36
|
|
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia, file dfe4d228-ff5f-bb0a-e053-d805fe0a78d9
|
27
|
|
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients., file dfe4d22e-db5d-bb0a-e053-d805fe0a78d9
|
26
|
|
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib, file dfe4d22b-5af7-bb0a-e053-d805fe0a78d9
|
25
|
|
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report, file dfe4d22b-886e-bb0a-e053-d805fe0a78d9
|
25
|
|
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities, file dfe4d22e-6abc-bb0a-e053-d805fe0a78d9
|
21
|
|
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells, file dfe4d22b-ffcd-bb0a-e053-d805fe0a78d9
|
19
|
|
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance, file dfe4d22e-6aba-bb0a-e053-d805fe0a78d9
|
17
|
|
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic, file dfe4d22e-6d48-bb0a-e053-d805fe0a78d9
|
17
|
|
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma, file dfe4d22e-b665-bb0a-e053-d805fe0a78d9
|
17
|
|
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22), file dfe4d22b-dbce-bb0a-e053-d805fe0a78d9
|
16
|
|
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib, file dfe4d22c-1ae9-bb0a-e053-d805fe0a78d9
|
16
|
|
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein, file dfe4d227-0251-bb0a-e053-d805fe0a78d9
|
15
|
|
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment, file dfe4d22b-8b22-bb0a-e053-d805fe0a78d9
|
15
|
|
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions, file dfe4d22e-bf74-bb0a-e053-d805fe0a78d9
|
15
|
|
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res, file dfe4d229-1692-bb0a-e053-d805fe0a78d9
|
14
|
|
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors, file dfe4d22b-5af8-bb0a-e053-d805fe0a78d9
|
14
|
|
Implications of antidepressants use in breast cancer: A brief review, file 3376510f-3224-46bb-8281-fef77cae7a2e
|
13
|
|
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy, file dfe4d227-2b92-bb0a-e053-d805fe0a78d9
|
13
|
|
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53, file dfe4d229-d55d-bb0a-e053-d805fe0a78d9
|
13
|
|
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report, file dfe4d22c-1789-bb0a-e053-d805fe0a78d9
|
13
|
|
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer, file dfe4d22e-4910-bb0a-e053-d805fe0a78d9
|
13
|
|
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling, file dfe4d22e-478d-bb0a-e053-d805fe0a78d9
|
12
|
|
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells, file dfe4d22b-d88f-bb0a-e053-d805fe0a78d9
|
11
|
|
Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform, file dfe4d22b-e626-bb0a-e053-d805fe0a78d9
|
11
|
|
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma, file dfe4d22e-3615-bb0a-e053-d805fe0a78d9
|
9
|
|
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes, file dfe4d22e-e42f-bb0a-e053-d805fe0a78d9
|
8
|
|
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports, file 1199ddd1-ab6a-4637-b2d3-8c85c975dcfc
|
7
|
|
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer, file 2b43428e-4b42-4604-9890-d84e2cbca856
|
7
|
|
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report, file 86029422-85af-4841-b2bf-47c3eabb5cfa
|
7
|
|
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far, file 8cc35723-4cb2-4655-b839-50fe697431f9
|
7
|
|
IRF5 promotes the proliferation of human thyroid cancer cells., file dfe4d227-8fa2-bb0a-e053-d805fe0a78d9
|
7
|
|
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation., file dfe4d22e-8d2a-bb0a-e053-d805fe0a78d9
|
7
|
|
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience, file dfe4d22e-d8e7-bb0a-e053-d805fe0a78d9
|
5
|
|
Biomarkers and prognostic factors for malignant pleural mesothelioma, file dfe4d226-ff65-bb0a-e053-d805fe0a78d9
|
3
|
|
Combined use of sonographic and elastosonographic parameters can improve the diagnostic accuracy in thyroid nodules at risk of malignancy at cytological examination, file d94d5e3e-569b-43c0-9106-df5ff632acca
|
2
|
|
Diagnosis of Chronic Myeloid Leukemia Early in Pregnancy, file dfe4d227-08c8-bb0a-e053-d805fe0a78d9
|
2
|
|
ROLE OF INTERFERON REGULATORY FACTOR 1 IN MONOCYTE/MACROPHAGE DIFFERENTIATION, file dfe4d227-2272-bb0a-e053-d805fe0a78d9
|
2
|
|
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia, file dfe4d227-2f0e-bb0a-e053-d805fe0a78d9
|
2
|
|
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report, file dfe4d22c-1787-bb0a-e053-d805fe0a78d9
|
2
|
|
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis, file 33438668-8c79-4538-be24-d2d87915ca7a
|
1
|
|
The PU.1 transcription factor induces cyclin D2 expression in U937 cells, file dfe4d226-fa9c-bb0a-e053-d805fe0a78d9
|
1
|
|
Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded, file dfe4d226-fad9-bb0a-e053-d805fe0a78d9
|
1
|
|
POSSIBLE ROLE OF THE TRANSCRIPTION FACTOR IRF-1 (IRF-1) IN THE REGULATION OF ORNITHINE DECARBOXYLASE GENE (ODC) GENE EXPRESSION DURING IFNg MACROPHAGE ACTIVATION, file dfe4d227-1867-bb0a-e053-d805fe0a78d9
|
1
|
|
Involvment of Interferon Regulatory Factor-1 in Monocyte CD95 Expression and CD95 mediated-Apoptosis, file dfe4d227-2175-bb0a-e053-d805fe0a78d9
|
1
|
|
SELECTIVE INHIHBITION OF LEUKEMIA CELL PROLIFERATION BY BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES SCIENCE, file dfe4d227-4183-bb0a-e053-d805fe0a78d9
|
1
|
|
THE INTERFERON REGULATORY FACTORS 1 AND 2 BIND TO A SEGMENT OF THE HUMAN C-MYB FIRST INTRON: POSSIBLE ROLE IN THE REGULATION OF C-MYB EXPRESSION, file dfe4d227-48af-bb0a-e053-d805fe0a78d9
|
1
|
|
Pyrrolidinedithiocarbamate induces apoptosis in human acute myelogenous leukemic cells affecting NF-kappaB activity, file dfe4d227-7cde-bb0a-e053-d805fe0a78d9
|
1
|
|
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives, file dfe4d22b-d3e2-bb0a-e053-d805fe0a78d9
|
1
|
|
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report, file dfe4d22b-dbcc-bb0a-e053-d805fe0a78d9
|
1
|
|
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes, file dfe4d22d-011a-bb0a-e053-d805fe0a78d9
|
1
|
| Totale |
881 |